TRADING UPDATES: Aurrigo wins deal; Dekel palm oil output up
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 12.25p on 14-05-2026 at 08:07:35 |
|---|---|
| Change | 0.00p 0% |
| Buy | 12.50p |
| Sell | 12.00p |
| Last Trade: | Buy 32.00 at 12.50p |
| Day's Volume: | 20,446 |
| Last Close: | 12.25p |
| Open: | 12.25p |
| ISIN: | GB00BLF79J41 |
| Day's Range | 12.25p - 12.25p |
| 52wk Range: | 5.25p - 13.00p |
| Market Capitalisation: | £30.76m |
| VWAP: | 12.35282p |
| Shares in Issue: | 251.08m |
Sector: Medical Services
Listed In: FTSE AIM All-Share,
Abingdon Healt. (ABDX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 32 | 12.50p | Ordinary |
09:07:34 - 14-May-26 |
| Buy* | 53 | 12.50p | Ordinary |
08:54:04 - 14-May-26 |
| Sell* | 7,111 | 12.128p | Ordinary |
08:53:19 - 14-May-26 |
| Buy* | 3,292 | 12.50p | Ordinary |
08:52:15 - 14-May-26 |
| Buy* | 2,000 | 12.50p | SI Trade |
08:52:15 - 14-May-26 |
| Buy* | 28 | 12.50p | SI Trade |
08:52:15 - 14-May-26 |
| Sell* | 250 | 12.00p | SI Trade |
08:52:15 - 14-May-26 |
| Sell* | 40 | 12.00p | SI Trade |
08:52:15 - 14-May-26 |
| Sell* | 409 | 12.0025p | Ordinary |
08:36:03 - 14-May-26 |
| Sell* | 31 | 12.0025p | Ordinary |
08:36:02 - 14-May-26 |
Abingdon Healt. (ABDX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 11th May 2026 7:00 am | RNS-R | Launch of LVOne Stroke Test by UpFront Diagnostics |
| 7th May 2026 5:38 pm | RNS | Holding(s) in Company |
| 6th May 2026 7:00 am | RNS-R | Update on Partnership with 4TEEN4 Pharmaceuticals |
| 21st Apr 2026 7:00 am | RNS | Admission to trading on OTCQB in the US |
| 15th Apr 2026 7:00 am | RNS | EMI Share Option Scheme |
| 14th Apr 2026 7:00 am | RNS | Trading to commence on the OTCQB in the US |
| 30th Mar 2026 7:00 am | RNS | £4.8m contracts awarded |
| 17th Mar 2026 7:00 am | RNS | Half-year Financial Report |
| 17th Mar 2026 7:00 am | RNS | Half-year Financial Report |
| 12th Mar 2026 7:00 am | RNS | $2.5m Contract for clinical self-test development |